ClinVar Miner

Submissions for variant NM_005633.4(SOS1):c.73C>T (p.Pro25Ser)

gnomAD frequency: 0.00082  dbSNP: rs139592595
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen RASopathy Variant Curation Expert Panel RCV000521504 SCV000616436 benign RASopathy 2017-04-03 reviewed by expert panel curation The filtering allele frequency of the c.73C>T (p.Pro25Ser) variant in the SOS1 gene is 0.23% for African chromosomes by the Exome Aggregation Consortium (21/6116 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert panel for autosomal dominant RASopathy variants (BA1).
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000154848 SCV000204530 likely benign not specified 2012-03-19 criteria provided, single submitter clinical testing p.Pro25Ser in Exon 01 of SOS1: This variant is not expected to have clinical sig nificance because it has been identified in 0.3% (12/3732) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs139592595).
GeneDx RCV001711220 SCV000209065 benign not provided 2019-01-11 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000154848 SCV000224487 likely benign not specified 2015-06-18 criteria provided, single submitter clinical testing
Invitae RCV000521504 SCV000659152 likely benign RASopathy 2024-01-15 criteria provided, single submitter clinical testing
Ambry Genetics RCV002381283 SCV002673540 benign Cardiovascular phenotype 2019-03-26 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Fulgent Genetics, Fulgent Genetics RCV002482943 SCV002796697 likely benign Fibromatosis, gingival, 1; Noonan syndrome 4 2021-12-18 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001711220 SCV004145981 benign not provided 2022-09-01 criteria provided, single submitter clinical testing SOS1: BS1, BS2
PreventionGenetics, part of Exact Sciences RCV003934876 SCV004754123 likely benign SOS1-related disorder 2019-10-07 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.